A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

The panel meeting for Moderna's RSV shot, scheduled for later this month, will be the "first time for investors to see the ...

A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...

The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...

The CDC currently recommends a single dose of the ... U.S.-listed shares of GSK, which markets rival RSV shot Arexvy, fell 2.5% to $41.44, while those of Pfizer, which sells RSV shot Abrysvo ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

Note that some links may require registration or subscription. A physician who supplied Matthew Perry with ketamine prior to ...

The ACIP advises the CDC on who should get the shots after they are approved by the U.S. Food and Drug Administration. The panel meeting for Moderna's RSV shot, scheduled for later this month ...

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...